Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 5;8(7):e65281.
doi: 10.1371/journal.pone.0065281. Print 2013.

A new method for the detection of neutralizing antibodies against mumps virus

Affiliations

A new method for the detection of neutralizing antibodies against mumps virus

Keita Matsubara et al. PLoS One. .

Abstract

Neutralization test is the most reliable method of evaluating immunity against viral diseases but there is no standard procedure for mumps virus, with tests differing in the infectivity of the challenge virus, 50% plaque reduction or complete inhibition of cytopathic effects (CPE), and usage of complement. A reliable, easy, and simple neutralization test for mumps virus was developed in this study. A recombinant mumps virus expressing GFP was generated as a challenge virus. Complement was added to the neutralizing mixture at 1∶200 when stocked serum samples were used. Neutralizing antibody titers were expressed as the reciprocal of the highest dilution that did not exceed two-fold of FU values (GFP expression) of the cell control wells. A total of 1,452 serum samples were assayed by inhibition of GFP expression in comparison with those examined by conventional 100% inhibition of CPE. 1,367 (94.1%) showed similar neutralizing antibody titers when examined by both methods. The GFP expression inhibition assay, using a recombinant mumps virus expressing GFP, is a simple and time- saving method.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Genome construction of the recombinant mumps Hoshino strain expressing GFP and expression of GFP.
Vero cells were infected with GFP Hoshino mumps strain at m.o.i. = 0.02 and subjected to experiments for GFP expression with fluoro EIA and microscopic examination on day 1, 3 and 5 of infection in comparison with mock-infection. Infectivity was assayed in culture supernatants on day 1, 3, and 5 of infection.
Figure 2
Figure 2. Relationship between the appearance of CPE and GFP expression.
Serial two-fold dilutions from 1∶4 to 1∶256 were mixed with an equal volume of challenge virus. In the left panel, the schematic results of two neutralization methods are shown. CPE was observed in one of the two wells at 1∶32, and the conventional neutralizing antibody titer was 1∶16 by 100% inhibition of CPE. The mean FU value of the two cell control wells was 202 and that of the 1∶32 dilution was 450, showing 1∶16 of neutralizing antibody titer. Using 1,452 serum samples, the consistency of neutralizing antibody titers was compared based on different cut-off values for GFP expression: 1.5-fold, 2.0-fold, and 2.5- fold of FU values of the cell control wells.
Figure 3
Figure 3. Effects of freeze-thawing and inactivation at 56°C for 30 min on neutralizing antibody titers.
Upper panel shows the neutralizing antibody titers of eight fresh sera (A–H), without inactivation and after three or five rounds of freeze-thawing. Lower panel shows the results of neutralizing antibody titers after inactivation.
Figure 4
Figure 4. Neutralizing antibody titers of non-inactivated and inactivated sera with the addition of complement.
Neutralizing antibody titers were examined in five sera (A–E) before and after inactivation. Complement was added at 1∶200, 1∶400, 1∶800, and 1∶1600 to the neutralizing mixture when inactivated sera were used. Each experiment was done in triplicate and mean titers were shown.
Figure 5
Figure 5. Effect of the addition of complement in 21 fresh and 227 stocked serum samples.
Distribution of serum samples is shown for neutralizing antibody titers assayed without inactivation and for those assayed after inactivation with the addition of complement, using 21fresh serum samples (left panel). 227 stocked serum samples were assayed in a similar manner (right panel).

Similar articles

Cited by

References

    1. Carbone KM, Rubin S (2007) Mumps virus. In: Knipe DM, Howley PM, editors. Fields Virology, 5th edition. Philadelphia, Lippincott, Williams & Wilkins. 1527–1550.
    1. Lamb RA, Parks GD (2007) Paramyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. 5th edition. Philadelphia, Lippincott Williams and Wilkins. 1449–1496.
    1. Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, et al. (2001) Localization of a new neutralizing epitope on the mumps virus hemagglutinin -neuraminidase protein. Virus Research 74: 133–137. - PubMed
    1. Örvell C, Tecle T, Johansson B, Saito H, Samuelson A (2002) Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 83: 2489–2496. - PubMed
    1. Nagai T, Okafuji T, Miyazaki C, Ito Y, Kamada M, et al. (2007) A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine 25: 2742–2747. - PubMed

MeSH terms